BIOMAT Database Logo BIOMAT Database Logo

Transcriptional control by myb oncogene product. 1992

S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Laboratory of Molecular Genetics, Tsukuba Life Science Center, Ibaraki, Japan.

Structure and function of two domains of c-Myb were analyzed. We show that a leucine zipper structure is a component of the negative regulatory domain, because its disruption markedly increases both the transactivating and transforming capacities of c-Myb. Our results suggest that an inhibitor which suppresses transactivation binds to c-Myb through the leucine zipper, and that c-Myb can be oncogenically activated by mis-sense mutation. We also proposed a model, the "tryptophan cluster", for the structure of the Myb DNA-binding domain, in which the three tryptophans form a cluster in the hydrophobic core in each repeat. The results of NMR analysis of repeat 3 revealed that the conserved tryptophans play a key role to make the hydrophobic core.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005809 Genes, Regulator Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions. Gene, Regulator,Regulator Gene,Regulator Genes,Regulatory Genes,Gene, Regulatory,Genes, Regulatory,Regulatory Gene
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Transcriptional trans-repression by the c-myb proto-oncogene product.
September 1989, Nucleic acids research,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb.
July 1989, Cell,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
The Myb oncogene product induces DNA-bending.
April 1994, Oncogene,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Nuclear compartmentalization of the v-myb oncogene product.
November 1985, Molecular and cellular biology,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Transcriptional control of flavonoid biosynthesis by MYB-bHLH-WDR complexes.
March 2015, Trends in plant science,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
The myb oncogene.
June 1990, Biochimica et biophysica acta,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
The myb oncogene.
January 1986, Gene amplification and analysis,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Presence of circulating anti-c-myb oncogene product antibodies in human sera.
March 1991, International journal of cancer,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I.
January 1992, Journal of virology,
S Ishii, and T Nomura, and C Kanei-Ishii, and H Nakagoshi, and T Sudo, and T Sawazaki
Transcriptional activation by human c-myb and v-myb genes.
May 1990, Oncogene,
Copied contents to your clipboard!